Overexpression of EPAS1 mRNA in CRC of patients without pre‐operative chemo‐radiotherapy and reduced expression in CRC of patients receiving pre‐operative chemo‐radiotherapy further confirms the oncogenic potential of EPAS1 in CRC. This evidence concerns the gene EPAS1 and colorectal carcinoma.